CI
LH icon

Cambiar Investors’s Labcorp LH Stock Holding History

Cambiar Investors’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.9M Buy
205,604
+10,289
+5% +$2.79M 2.54% 8
2025
Q4 		$49M Sell
195,315
-2,554
-1% -$678K 2.19% 18
2025
Q3 		$56.8M Sell
197,869
-55,367
-22% -$14.8M 2.58% 3
2025
Q2 		$66.5M Sell
253,236
-9,708
-4% -$2.36M 2.8% 4
2025
Q1 		$61.2M Sell
262,944
-5,506
-2% -$1.34M 2.59% 5
2024
Q4 		$61.6M Sell
268,450
-7,192
-3% -$1.65M 2.44% 5
2024
Q3 		$61.6M Sell
275,642
-4,521
-2% -$994K 2.37% 4
2024
Q2 		$57M Buy
280,163
+38,414
+16% +$7.81M 2.23% 6
2024
Q1 		$52.8M Buy
241,749
+1,212
+0.5% +$267K 1.97% 16
2023
Q4 		$54.7M Sell
240,537
-911
-0.4% -$191K 2.15% 11
2023
Q3 		$48.5M Sell
241,448
-3,908
-2% -$824K 2.06% 10
2023
Q2 		$50.9M Buy
245,356
+6,502
+3% +$1.26M 2.15% 8
2023
Q1 		$47.1M Sell
238,854
-4,189
-2% -$862K 2.03% 12
2022
Q4 		$49.2M Buy
+243,043
New +$47.5M 2.24% 5

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cambiar Investors's LH Position: Q1 2026 in Review

Cambiar Investors increased its Labcorp (LH) stake by 5.3% in Q1 2026, buying an estimated $2.79M and bringing the position to 205,604 shares worth $54.9M. The position accounts for 2.54% of the portfolio, ranked #8.

Cambiar Investors first reported a position in LH in Q4 2022 and has held it in 14 quarters since. The position peaked at $66.5M in Q2 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Cambiar Investors held 205,604 shares of Labcorp worth $54.9M as of Q1 2026.
  • Cambiar Investors bought 10,289 Labcorp shares in Q1 2026, an estimated $2.79M.
  • Labcorp made up 2.54% of Cambiar Investors's portfolio in Q1 2026, its #8 holding.
  • Cambiar Investors first reported a position in Labcorp in Q4 2022 and has held it in 14 quarters since.
  • Cambiar Investors's Labcorp position peaked at $66.5M in Q2 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Cambiar Investors's 13F filing for Q1 2026, filed 12 May 2026.